Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
7.25
+1.10 (17.89%)
At close: Nov 13, 2026, 4:00 PM EST
7.11
-0.14 (-1.93%)
Pre-market: Nov 16, 2026, 7:15 AM EST

Orchestra BioMed Holdings Revenue

Orchestra BioMed Holdings had revenue of $91.00K in the quarter ending September 30, 2026, a decrease of -89.43%. This brings the company's total for the last twelve months to $31.21M, up 1,007.38% year-over-year. In the year 2025, Orchestra BioMed Holdings had annual revenue of $33.48M with 1,169.22% growth. That makes Orchestra BioMed Holdings the 31,133rd largest company in the world by revenue and 4,103rd in the United States.

Revenue (ttm)
$31.21M
Revenue Growth
+1,007.38%
P/S Ratio
18.29
Revenue / Employee
$362,860
Employees
86
Market Cap
570.61M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202533.48M30.84M1,169.22%
Dec 31, 20242.64M-122.00K-4.42%
Dec 31, 20232.76M-773.00K-21.88%
Dec 31, 20223.53M4.32M-
Dec 31, 2021-782.00K-6.49M-
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.